Gateway Investment Advisers LLC Astrazeneca PLC Transaction History
Gateway Investment Advisers LLC
- $8.93 Billion
- Q4 2024
A detailed history of Gateway Investment Advisers LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 3,129 shares of AZN stock, worth $208,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,129
Previous 4,883
35.92%
Holding current value
$208,391
Previous $380,000
46.05%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.19 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.8 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...